BenzingaOctober 1, 2026 at 5:04 AM NY26 Days Ago
RBC Capital Maintains Outperform on DexCom, Raises Price Target to $105
RBC Capital analyst Kendall Au maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $90 to $105.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
